This book is a key resource for all hematologists managing patients with myelodysplastic syndromes and provides a comprehensive overview of the etiology, pathogenesis, clinical presentation, diagnosis, and classification as well as current and emerging therapies for these disorders. This accessible text will provide an informative and practical approach towards managing these patients in the daily clinical setting.
Myelodysplastic syndromes are a group of disorders that occur when the bone marrow does not work effectively and fails to make enough healthy blood cells. People with myelodysplastic syndromes can lack the amount right of red blood cells, white blood cells, and platelets, and most experts agree that myelodysplastic syndromes should be considered a cancer of the blood and bone marrow. Myelodysplastic syndromes may be diagnosed at any age but the media age at diagnosis is between 65 and 75 years of age and over 90% of patients are over 50 years of age at the time of diagnosis. Recent advances have seen a range of new therapies being developed to treat these disorders and this book captures the latest data and clinical recommendations on these updates.